TY - JOUR
T1 - The formation of subsequent inter-firm R&D partnerships between large pharmaceutical companies and small, entrepreneurial biotechnology firms - How important is inter-organisational trust?
AU - Hagedoorn, J.
AU - Roijakkers, A.H.W.M.
AU - van Kranenburg, H.L.
PY - 2008/1/1
Y1 - 2008/1/1
N2 - This paper analyses the role of inter-organisational trust in pharmaceutical biotechnology, all industry characterised by a strong dual market structure. Our main finding is that repeated ties in pairs of large pharmaceutical companies and small, entrepreneurial biotechnology firms, which indicate inter-organisational trust, have a negative effect on Subsequent partnering. An explanation for this result is found in specific conditions for R&D partnering in this high-technology dual market structure. Partnerships between a small number of very large companies and a large group of dependent small companies are not characterised by Mutual dependence and inter-organisational trust.
AB - This paper analyses the role of inter-organisational trust in pharmaceutical biotechnology, all industry characterised by a strong dual market structure. Our main finding is that repeated ties in pairs of large pharmaceutical companies and small, entrepreneurial biotechnology firms, which indicate inter-organisational trust, have a negative effect on Subsequent partnering. An explanation for this result is found in specific conditions for R&D partnering in this high-technology dual market structure. Partnerships between a small number of very large companies and a large group of dependent small companies are not characterised by Mutual dependence and inter-organisational trust.
U2 - 10.1504/IJTM.2008.020699
DO - 10.1504/IJTM.2008.020699
M3 - Article
SN - 0267-5730
VL - 44
SP - 81
EP - 92
JO - International Journal of Technology Management
JF - International Journal of Technology Management
IS - 1/2
ER -